Invitrogen Scientist Settles Insider Trading Case
The U.S. Securities and Exchange Commission has settled a lawsuit alleging that a former scientist at biotech company Invitrogen Corp. engaged in insider trading based on information he obtained at a...To view the full article, register now.
Already a subscriber? Click here to view full article